T Suehiro
Overview
Explore the profile of T Suehiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miuma S, Miyaaki H, Miyazoe Y, Suehiro T, Sasaki R, Shibata H, et al.
Transplant Proc
. 2018 Feb;
50(1):222-225.
PMID: 29407313
Sofosbuvir plus ledipasvir (SOF-LDV) combination therapy is a promising therapy for post-transplant hepatitis C virus (HCV) reinfection. It is known that gastric pH elevation induces lower absorption of ledipasvir; therefore,...
2.
Eriguchi M, Tsuruya K, Yoshida H, Yamada S, Tanaka S, Suehiro T, et al.
Perit Dial Int
. 2011 Nov;
31(6):698-700.
PMID: 22123857
No abstract available.
3.
Sumida Y, Nakayama M, Nagata M, Nakashita S, Suehiro T, Kaizu Y, et al.
Clin Nephrol
. 2010 Apr;
73(5):360-9.
PMID: 20420796
Aims: Vascular calcification and atherosclerosis frequently develop in end-stage renal disease (ESRD). Although several reports have investigated both carotid artery calcification (CAAC) and carotid atherosclerosis in ESRD patients, the relationship...
4.
Ikeda Y, Suehiro T, Itahara T, Inui Y, Chikazawa H, Inoue M, et al.
Clin Nephrol
. 2007 Jun;
67(6):358-65.
PMID: 17598371
Aims: Human serum paraoxonase (PON1) is associated with high-density lipoprotein, and inhibits oxidative modification of low-density lipoprotein. Therefore, PON1 is supposed to contribute to the prevention of atherosclerosis. We and...
5.
Suehiro T, Kuwano H
Chirurgia (Bucur)
. 2007 Feb;
101(6):569-70.
PMID: 17283831
No abstract available.
6.
Strong green emission from alpha-SiAlON activated by divalent ytterbium under blue light irradiation
Xie R, Hirosaki N, Mitomo M, Uheda K, Suehiro T, Xu X, et al.
J Phys Chem B
. 2006 Jul;
109(19):9490-4.
PMID: 16852140
This contribution reports on luminescence properties of divalent ytterbium in alpha-SiAlON at room temperature. Ytterbium-doped alpha-SiAlON powders, with the compositions of (M(1-2x/v)Yb(x))(m/v)Si(12-m-n)Al(m+n)O(n)N(16-n) (M = Ca, Li, Mg, and Y, v...
7.
Ikeda Y, Suehiro T, Osaki F, Tsuzura S, Arii K, Kumon Y, et al.
Diabet Med
. 2005 Apr;
22(5):661-2.
PMID: 15842527
No abstract available.
8.
Ikeda Y, Suehiro T, Osaki F, Tsuzura S, Kumon Y, Hashimoto K
Diabet Med
. 2004 Sep;
21(10):1113-20.
PMID: 15384959
Aims: Protein kinase C (PKC), a serine/threonine kinase, is known to be activated in various tissues under hyperglycaemic conditions. Notably, PKCbeta, a member of the conventional PKC group, is the...
9.
Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M, et al.
Transpl Int
. 2004 Jun;
17(6):310-6.
PMID: 15221124
Graft size is known to be a major risk factor in living donor adult liver transplantation (LDALT). The aim of this study is to reassess whether graft size is a...
10.
Ninomiya M, Shimada M, Harada N, Soejima Y, Suehiro T, Maehara Y
Br J Surg
. 2004 Feb;
91(2):184-90.
PMID: 14760666
Background: Oxidative stress contributes to hepatic ischaemia-reperfusion (IR) injury in a biphasic pattern. In addition to direct cytotoxic effects, oxidative stress also initiates the signal transduction processes that promote second-phase...